HIGHLIGHTS
- who: Nebojsa Skorupan et al. from the Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA have published the research work: Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma, in the Journal: Cancers 2022, 14, 4209. of /2022/
- what: The aim of this review is to provide an update for physicians and laboratory scientists on the clinical progress of novel therapeutics purported to target and remodel the PDAC TME. The authors focused on biologics (including monoclonal_antibodies) and small_molecules that can be administered off-the-shelf to patients to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.